
Discovering A Breakthrough: Gilead's Long-Standing Commitment To Helping Change The Course Of HIV
(MENAFN- 3BL) In 2006, Tomas Cihlar knew all too well that despite initial successes with combination treatment, HIV was firmly holding ground around the globe and existing therapies were limited. He was 12 years into his virology research career at Gilead …